REFERENCES
1. Toraih EA, Elshazli RM, Hussein MH, Elgaml A, Amin MN, El-Mowafy M, El-Mesery M, Ellythy A, Duchesne J, Killackey MT et al. 2020. Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in covid-19 patients: A meta-regression and decision tree analysis. J Med Virol.
2. Covid C, COVID C, COVID C, Bialek S, Gierke R, Hughes M, McNamara LA, Pilishvili T, Skoff T. 2020. Coronavirus disease 2019 in children—united states, february 12–april 2, 2020. Morbidity and Mortality Weekly Report. 69(14):422.
3. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F, Carson G. 2020. Features of 16,749 hospitalised uk patients with covid-19 using the isaric who clinical characterisation protocol. medRxiv.
4. Viner RM, Whittaker E. 2020. Kawasaki-like disease: Emerging complication during the covid-19 pandemic. Lancet. 395(10239):1741-1743.
5. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, Liu X, Wei L, Truelove SA, Zhang T. 2020. Epidemiology and transmission of covid-19 in 391 cases and 1286 of their close contacts in shenzhen, china: A retrospective cohort study. The Lancet Infectious Diseases.
6. Zhang J, Litvinova M, Liang Y, Wang Y, Wang W, Zhao S, Wu Q, Merler S, Viboud C, Vespignani A et al. 2020. Changes in contact patterns shape the dynamics of the covid-19 outbreak in china. Science. 368(6498):1481-1486.
7. Cheung EW, Zachariah P, Gorelik M, Boneparth A, Kernie SG, Orange JS, Milner JD. 2020. Multisystem inflammatory syndrome related to covid-19 in previously healthy children and adolescents in new york city. JAMA.
8. Chiu JS, Lahoud-Rahme M, Schaffer D, Cohen A, Samuels-Kalow M. 2020. Kawasaki disease features and myocarditis in a patient with covid-19. Pediatr Cardiol.1-3.
9. Rowley AH, Shulman ST. 2010. Pathogenesis and management of kawasaki disease. Expert Rev Anti Infect Ther. 8(2):197-203.
10. Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB. 2010. Hospitalizations for kawasaki syndrome among children in the united states, 1997-2007. Pediatric Infectious Disease Journal. 29(6):483-488.
11. Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. 2005. Association between a novel human coronavirus and kawasaki disease. J Infect Dis. 191(4):499-502.
12. Shirato K, Imada Y, Kawase M, Nakagaki K, Matsuyama S, Taguchi F. 2014. Possible involvement of infection with human coronavirus 229e, but not nl63, in kawasaki disease. J Med Virol. 86(12):2146-2153.
13. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, Bonanomi E, D’Antiga L. 2020. An outbreak of severe kawasaki-like disease at the italian epicentre of the sars-cov-2 epidemic: An observational cohort study. Lancet. 395(10239):1771-1778.
14. Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, Newburger JW, Kleinman LC, Heidemann SM, Martin AA et al. 2020. Multisystem inflammatory syndrome in u.S. Children and adolescents. N Engl J Med.
15. Pilania RK, Jindal AK, Srikrishna VV, Samprathi M, Singhal M, Singh S. 2019. Hypotension in a febrile child-beware of kawasaki disease shock syndrome. J Clin Rheumatol.
16. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. 2020. Hyperinflammatory shock in children during covid-19 pandemic. Lancet. 395(10237):1607-1608.
17. McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Group atP-D. 2018. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: The prisma-dta statement. JAMA. 319(4):388-396.
18. Behmadi M, Alizadeh B, Malek A. 2019. Comparison of clinical symptoms and cardiac lesions in children with typical and atypical kawasaki disease. Med Sci (Basel). 7(4).
19. Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH. 2012. Closing the gap between methodologists and end-users: R as a computational back-end. 2012. 49(5):15.
20. Pierce CA. 2008. Software review: Borenstein, m., hedges, l. V., higgins, j. P. T., & rothstein, h. R. (2006). Comprehensive meta-analysis (version 2.2.027) [computer software]. Englewood, nj: Biostat. Organizational Research Methods. 11(1):188-191.
21. DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Control Clin Trials. 7(3):177-188.
22. Andreano A, Rebora P, Valsecchi MG. 2015. Measures of single arm outcome in meta-analyses of rare events in the presence of competing risks. Biometrical Journal. 57(4):649-660.
23. Lin L, Chu H. 2018. Quantifying publication bias in meta-analysis. Biometrics. 74(3):785-794.
24. Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. 2020. Clinical and ct features in pediatric patients with covid-19 infection: Different points from adults. Pediatr Pulmonol. 55(5):1169-1174.
25. Capone CA, Subramony A, Sweberg T, Schneider J, Shah S, Rubin L, Schleien C, Northwell Health C-RC, Epstein S, Johnson JC et al. 2020. Characteristics, cardiac involvement, and outcomes of multisystem inflammatory disease of childhood (mis-c) associated with sars-cov-2 infection. J Pediatr.
26. Park YW, Han JW, Park IS, Kim CH, Yun YS, Cha SH, Ma JS, Lee SB, Kim CH, Lee HJ et al. 2005. Epidemiologic picture of kawasaki disease in korea, 2000-2002. Pediatr Int. 47(4):382-387.
27. Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J. 2009. Risk factors for kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr. 168(11):1315-1321.
28. de La Harpe M, di Bernardo S, Hofer M, Sekarski N. 2019. Thirty years of kawasaki disease: A single-center study at the university hospital of lausanne. Frontiers in Pediatrics. 7(11).
29. Yan F, Pan B, Sun H, Tian J, Li M. 2019. Risk factors of coronary artery abnormality in children with kawasaki disease: A systematic review and meta-analysis. Frontiers in pediatrics. 7:374-374.
30. Shulman ST, Rowley AH. 2015. Kawasaki disease: Insights into pathogenesis and approaches to treatment. Nat Rev Rheumatol. 11(8):475-482.
31. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X et al. 2020. Clinical course and risk factors for mortality of adult inpatients with covid-19 in wuhan, china: A retrospective cohort study. Lancet. 395(10229):1054-1062.
32. McGonagle D, Sharif K, O’Regan A, Bridgewood C. 2020. The role of cytokines including interleukin-6 in covid-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmunity Reviews. 19(6):102537.
33. De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P et al. 2012. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. New England Journal of Medicine. 367(25):2385-2395.
34. Forster P, Forster L, Renfrew C, Forster M. 2020. Phylogenetic network analysis of sars-cov-2 genomes. Proceedings of the National Academy of Sciences. 117(17):9241.
35. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. 2020. Hyperinflammatory shock in children during covid-19 pandemic. Lancet. 395(10237):1607-1608.
36. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, Bonanomi E, D’Antiga L. 2020. An outbreak of severe kawasaki-like disease at the italian epicentre of the sars-cov-2 epidemic: An observational cohort study. Lancet.
37. Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C, Fitzgerald JC, Topjian A, John ARO. 2020. Multisystem inflammatory syndrome in children during the covid-19 pandemic: A case series. J Pediatric Infect Dis Soc.
38. Grimaud M, Starck J, Levy M, Marais C, Chareyre J, Khraiche D, Leruez-Ville M, Quartier P, Leger PL, Geslain G et al. 2020. Acute myocarditis and multisystem inflammatory emerging disease following sars-cov-2 infection in critically ill children. Ann Intensive Care. 10(1):69.
39. Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, Debray A, Basmaci R, Salvador E, Biscardi S et al. 2020. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in paris, france: Prospective observational study. BMJ. 369:m2094.
40. Miller J, Cantor A, Zachariah P, Ahn D, Martinez M, Margolis K. 2020. Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (mis-c) that is related to covid-19: A single center experience of 44 cases. Gastroenterology.
41. Perez-Toledo M, Faustini SE, Jossi SE, Shields AM, Kanthimathinathan HK, Allen JD, Watanabe Y, Goodall M, Wraith DC, Veenith TV et al. 2020. Serology confirms sars-cov-2 infection in pcr-negative children presenting with paediatric inflammatory multi-system syndrome. medRxiv.
42. Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, Ramnarayan P, Fraisse A, Miller O, Davies P et al. 2020. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with sars-cov-2. JAMA.
43. Blondiaux E, Parisot P, Redheuil A, Tzaroukian L, Levy Y, Sileo C, Schnuriger A, Lorrot M, Guedj R, Ducou le Pointe H. 2020. Cardiac mri of children with multisystem inflammatory syndrome (mis-c) associated with covid-19: Case series. Radiology.202288.
44. Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, Bensaid P, Pichard S, Kouider H, Morelle G et al. 2020. Paediatric multisystem inflammatory syndrome temporally associated with sars-cov-2 mimicking kawasaki disease (kawa-covid-19): A multicentre cohort. Ann Rheum Dis.
45. Ramcharan T, Nolan O, Lai CY, Prabhu N, Krishnamurthy R, Richter AG, Jyothish D, Kanthimathinathan HK, Welch SB, Hackett S et al. 2020. Paediatric inflammatory multisystem syndrome: Temporally associated with sars-cov-2 (pims-ts): Cardiac features, management and short-term outcomes at a uk tertiary paediatric hospital. Pediatr Cardiol.1-11.
46. Kaushik S, Aydin SI, Derespina KR, Bansal PB, Kowalsky S, Trachtman R, Gillen JK, Perez MM, Soshnick SH, Conway EE, Jr. et al. 2020. Multisystem inflammatory syndrome in children (mis-c) associated with sars-cov-2 infection: A multi-institutional study from new york city. J Pediatr.
47. sermet i, temmam s, huon c, behillil s, gadjos v, bigot t, lurier t, chretien d, backovick m, Moisan-Delaunay A et al. 2020. Prior infection by seasonal coronaviruses does not prevent sars-cov-2 infection and associated multisystem inflammatory syndrome in children. medRxiv.2020.2006.2029.20142596.